Transurethral columnar balloon dilation of the prostate for small volume prostatic hyperplasia:a single-center,open,randomized controlled clinical trial
10.3969/j.issn.1009-8291.2023.10.002
- VernacularTitle:柱状水囊前列腺扩开术治疗小体积前列腺增生：一项单中心开放随机对照临床试验
- Author:
Dali HE
1
;
Zhen YAO
1
;
Dong CUI
1
;
Fengqi YAN
1
;
Yong JIAO
1
;
Qiang FU
1
Author Information
1. Department of Urology, Tangdu Hospital, Air Force Military Medical University, Xi’an 710038, China
- Publication Type:Journal Article
- Keywords:
small volume prostatic hyperplasia;
transurethral columnar balloon dilation of the prostate;
transurethral resection of prostate;
sexual ability
- From:
Journal of Modern Urology
2023;28(10):830-834
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To compare the efficacy of transurethral columnar balloon dilation of the prostate (TUCBDP) and transurethral resection of prostate (TURP) in the treatment of small volume prostatic hyperplasia. 【Methods】 A total of 96 patients with small volume prostatic hyperplasia diagnosed in our hospital during Jan.2019 and Jan.2021 were enrolled and divided into the observation group and control group,with 48 patients in either group. The observation group received TUCBDP while the control group TURP. The International Prostate Symptom score (IPSS),Quality of Life Score (QOL), international index of erectile function-erectile function (IIEF-EF),maximum urinary flow rate (Qmax),postvoid residual urine (PVR) and maximum detrusor pressure (MDP) of the two groups were compared before surgery and 24 months after surgery. The surgery-related complications and occurrence of new or aggravated sexual dysfunction were observed. 【Results】 Both groups successfully completed the treatment. The operation time and indwelling catheterization time were shorter in the observation group than in the control group (P<0.05). The scores of QOL,IPSS and IIEF-EF,the levels of Qmax,PVR and MDP of both groups 24 months after surgery were significantly improved compared with those before surgery (P<0.05). The IPSS score of the observation group was lower than that of the control group 24 months after surgery (P<0.05),while the IIEF-EF score and Qmax of the observation group were higher than those of the control group (P<0.05). The incidences of surgery-related complications and new or aggravated sexual dysfunction were significantly lower in the observation group than in the control group (P<0.05). 【Conclusion】 TUCBDP is significantly effective in the treatment of small volume prostatic hyperplasia,showing greater advantages than TURP in improving postoperative IPSS,IIEF-EF score and Qmax,with higher safety.
